KERYX BIOPHARMACEUTICALS INC

NEW YORK, NY How do I update this listing?

Keryx Biopharmaceuticals is based out of New York. Acquires, develops and commercializes novel pharmaceutical products for the treatment of life-threatening diseases. As of Dec. 31, 2005, the company's lead product candidates were Sulonex for the treatment of diabetic nephropathy and KRX-0401 for the treatment of multiple forms of cancer.Whalewisdom has at least 232 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.

Create Alert

Contact Info

keryx biopharmaceuticals inc
750 LEXINGTON AVENUE
NEW YORK NY    10022

Business Phone: 212-531-5965
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Elevate your investments